Cargando…
Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics
Polo-like kinase 4 (PLK4) is the master regulator of centriole duplication in metazoan organisms. Catalytic activity and protein turnover of PLK4 are tightly coupled in human cells, since changes in PLK4 concentration and catalysis have profound effects on centriole duplication and supernumerary cen...
Autores principales: | Byrne, Dominic P., Clarke, Christopher J., Brownridge, Philip J., Kalyuzhnyy, Anton, Perkins, Simon, Campbell, Amy, Mason, David, Jones, Andrew R., Eyers, Patrick A., Eyers, Claire E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338032/ https://www.ncbi.nlm.nih.gov/pubmed/32501498 http://dx.doi.org/10.1042/BCJ20200309 |
Ejemplares similares
-
Strong anion exchange‐mediated phosphoproteomics reveals extensive human non‐canonical phosphorylation
por: Hardman, Gemma, et al.
Publicado: (2019) -
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells
por: Kerschner-Morales, Sophie L., et al.
Publicado: (2020) -
Effects of the PLK4 inhibitor Centrinone on the biological behaviors of acute myeloid leukemia cell lines
por: Mu, Xing-Ru, et al.
Publicado: (2022) -
Profiling the
Human Phosphoproteome to Estimate the
True Extent of Protein Phosphorylation
por: Kalyuzhnyy, Anton, et al.
Publicado: (2022) -
Plk4 and Aurora A cooperate in the initiation of acentriolar spindle assembly in mammalian oocytes
por: Bury, Leah, et al.
Publicado: (2017)